News

Routine blood pressure readings could flag dementia risk

New research suggests vascular aging markers may offer clinicians an early warning tool.
Written byAndrea Corona
| 2 min read
Image of a blood pressure cuff beside a stethoscope

Blood pressure could be used as a risk assessment tool for dementia.

CREDIT: Gemini

Register for free to listen to this article
Listen with Speechify
0:00
2:00

Two new studies presented at the American College of Cardiology's 75th Annual Scientific Session in New Orleans suggest that measurements derived from routine blood pressure readings could help identify adults at heightened risk for dementia — findings that researchers say may reshape how clinicians think about hypertension management.

The research, being presented at the three-day cardiology conference taking place March 28–30 at the Ernest N. Morial Convention Center, examines how patterns of arterial stiffness tracked over time relate to the onset of dementia. Both studies analyzed data from 8,536 participants in the SPRINT trial — a large, multicenter study of adults aged 50 and older with hypertension — over a five-year follow-up period, during which 323 participants developed probable dementia.

The first study found that pulse pressure-heart rate index, a figure calculated from heart rate and blood pressure measurements, independently predicted dementia risk among adults over 50. Participants under 65 with a higher pulse pressure-heart rate index faced a significantly elevated risk: each unit increase in the index was associated with a 76 percent higher risk of developing probable dementia or mild cognitive impairment.

The second study focused on estimated pulse wave velocity — a marker of vascular aging calculated from age and blood pressure — and found that adults with persistently elevated or rapidly increasing velocity were significantly more likely to develop dementia than those with more stable vascular profiles. The association held even after researchers controlled for factors including age, sex, kidney disease, cardiovascular history and smoking.

Continue reading below...
A repeating pattern of transparent laboratory flasks partially filled with purple liquid is arranged across a light lavender background.
ArticlesWhy reproducibility remains a challenge in preclinical research
Researchers are uncovering how hidden sources of variability throughout the experimental workflow can shape scientific outcomes.
Read More

"Blood pressure management isn't just about preventing heart attacks and strokes; it may also be one of the most actionable strategies for preserving cognitive health," said Newton Nyirenda, an epidemiologist at Georgetown University and lead author of both studies. "We need to start thinking about hypertension management much earlier than we typically have in order to address this in younger adults before damage starts to accumulate."

The clinical appeal of both metrics lies in their accessibility. Because pulse pressure-heart rate index and estimated pulse wave velocity are derived from data already collected during primary care visits, the researchers say risk scoring based on either measure could be incorporated into existing clinical workflows without significant additional burden.

The findings arrive against a backdrop of converging public health concerns. Nearly half of US adults have high blood pressure, a condition long associated with cardiovascular disease and increasingly linked to cognitive decline. Hypertension is very common in persons over the age of 50 and is a leading risk factor for heart disease, stroke, kidney failure, and a growing body of research suggests it may increase the risk for dementia later in life.

"Clinicians should focus on individualizing risk assessments and then tailoring treatment strategies that help patients improve cardiovascular health while preventing neurocognitive decline," said Sula Mazimba, an associate professor at the University of Virginia and senior author of the studies. "You don't want to wait until a patient starts manifesting cognitive decline before you act."

Researchers were careful to note the study's limitations. As a post hoc analysis of clinical trial data, the findings cannot establish causation. The participants were adults with hypertension and elevated cardiovascular risk, meaning results may not generalize to lower-risk populations. Further studies are needed to validate clinically actionable thresholds and to determine whether modifying vascular aging trajectories can meaningfully reduce dementia risk.

The full study, "Estimated Pulse Wave Velocity Trajectories and Risk of Incident Probable Dementia in SPRINT-MIND," is scheduled for presentation on Sunday, March 29.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

  • Drug Discovery News Placeholder Image

    Andrea Corona is the senior editor at Drug Discovery News, where she leads daily editorial planning and produces original reporting on breakthroughs in drug discovery and development. With a background in health and pharma journalism, she specializes in translating breakthrough science into engaging stories that resonate with researchers, industry professionals, and decision-makers across biotech and pharma.

    Prior to joining DDN, Andrea served as senior editor at Pharma Manufacturing, where she led feature coverage on pharmaceutical R&D, manufacturing innovation, and regulatory policy. Her work blends investigative reporting with a deep understanding of the drug development pipeline, and she is particularly interested in stories at the intersection of science, innovation and technology.

    View Full Profile

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Abstract illustration of a DNA double helix surrounded by geometric shapes, interconnected lines, and circular data-inspired design elements on a light background.
Discover how codon optimization influences gene expression, protein production, and synthetic DNA design across diverse expression systems.
Close-up 3D rendering of small extracellular vesicles budding from a cell membrane and floating through a fluid environment against a blue background.
Explore strategies for improving extracellular vesicle yield, purity, and reproducibility in biomanufacturing workflows.
Human anatomy. Flat design icons for medical theme
Discover how multi-system proteomics and metabolic phenotyping reveal the tissue-level cellular mechanisms behind modern obesity treatments.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue